Your browser doesn't support javascript.
loading
Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial.
Asgar, A; Chandrasekhar, J; Mikhail, G; Webb, J; Lefèvre, T; Tamburino, C; Hildick-Smith, D; Hambrecht, R; Van Belle, E; Widder, J; Dumonteil, N; Hink, U; Jeger, R; Linke, A; Deliargyris, E; Gao, P; Mehran, R; Hengstenberg, C; Anthopoulos, P; Dangas, G.
Afiliação
  • Asgar A; Division of Cardiology, Montreal Heart Institute, Montreal, Canada.
  • Chandrasekhar J; Icahn School of Medicine at Mount Sinai, The Zena and Michael a. Wiener Cardiovascular Institute, New York, New York.
  • Mikhail G; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Webb J; Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Lefèvre T; Ramsay Générale De Santé, Institut Hospitalier Jacques Cartier, Massy, France.
  • Tamburino C; Department of Cardiology, University of Catania, Catania, Italy.
  • Hildick-Smith D; Sussex Cardiac Centre-Brighton & Sussex University Hospitals NHS Trust, Brighton, East Sussex, United Kingdom.
  • Hambrecht R; Department of Cardiology and Angiology, Klinikum Links Der Weser, Bremen, Germany.
  • Van Belle E; Centre Hospitalier Universitaire De Lille, Lille, France.
  • Widder J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Dumonteil N; Department of Cardiology, Rangueil University Hospital, Toulouse, France.
  • Hink U; Cardiology Department, Johannes Gutenberg University Hospital, Mainz, Germany.
  • Jeger R; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
  • Linke A; Department of Internal Medicine/Cardiology, University of Leipzig, Heart Centre, Germany.
  • Deliargyris E; The Medicines Company, Parsippany, New Jersey.
  • Gao P; The Medicines Company, Parsippany, New Jersey.
  • Mehran R; Icahn School of Medicine at Mount Sinai, The Zena and Michael a. Wiener Cardiovascular Institute, New York, New York.
  • Hengstenberg C; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany, and Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Anthopoulos P; The Medicines Company, Zurich, Switzerland.
  • Dangas G; Icahn School of Medicine at Mount Sinai, The Zena and Michael a. Wiener Cardiovascular Institute, New York, New York.
Catheter Cardiovasc Interv ; 89(1): 144-153, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27152677
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Valva Aórtica / Estenose da Valva Aórtica / Fragmentos de Peptídeos / Cateterismo Cardíaco / Heparina / Antitrombinas / Implante de Prótese de Valva Cardíaca / Anticoagulantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged80 País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Valva Aórtica / Estenose da Valva Aórtica / Fragmentos de Peptídeos / Cateterismo Cardíaco / Heparina / Antitrombinas / Implante de Prótese de Valva Cardíaca / Anticoagulantes Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged80 País como assunto: America do norte / Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article